ANI Pharmaceuticals Inc (ANIP) — Cash Flow-to-Debt Ratio
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of $30.37 Million could theoretically repay 0% of its total liabilities ($899.65 Million) in one year. See ANI Pharmaceuticals Inc (ANIP) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ANI Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for ANI Pharmaceuticals Inc across 28 annual periods. Also explore how fast is ANI Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ANI Pharmaceuticals Inc (1998–2025)
Year-by-year debt coverage analysis for ANI Pharmaceuticals Inc. For market capitalisation and broader financial context, see ANI Pharmaceuticals Inc (ANIP) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $185.22 Million | $899.65 Million | ▲ +175.0% |
| 2024 | 0.07x | $64.02 Million | $855.17 Million | ▼ -71.9% |
| 2023 | 0.27x | $118.96 Million | $446.82 Million | ▲ +459.7% |
| 2022 | -0.07x | $-31.20 Million | $421.55 Million | ▼ -1019.9% |
| 2021 | 0.01x | $3.32 Million | $412.86 Million | ▼ -86.0% |
| 2020 | 0.06x | $15.27 Million | $265.49 Million | ▼ -69.3% |
| 2019 | 0.19x | $45.63 Million | $244.00 Million | ▼ -34.9% |
| 2018 | 0.29x | $67.07 Million | $233.34 Million | ▲ +73.1% |
| 2017 | 0.17x | $39.42 Million | $237.38 Million | ▼ -7.4% |
| 2016 | 0.18x | $27.47 Million | $153.22 Million | ▲ +30.0% |
| 2015 | 0.14x | $17.26 Million | $125.18 Million | ▼ -22.4% |
| 2014 | 0.18x | $22.03 Million | $123.92 Million | ▲ +111.5% |
| 2013 | -1.55x | $-5.48 Million | $3.54 Million | ▲ +35.1% |
| 2012 | -2.39x | $-25.28 Million | $10.59 Million | ▼ -22.5% |
| 2011 | -1.95x | $-47.87 Million | $24.56 Million | ▼ -24.5% |
| 2010 | -1.57x | $-40.10 Million | $25.62 Million | ▼ -75.0% |
| 2009 | -0.89x | $-18.43 Million | $20.61 Million | ▲ +77.8% |
| 2008 | -4.03x | $-15.54 Million | $3.85 Million | ▼ -926.0% |
| 2007 | 0.49x | $739.99K | $1.52 Million | ▲ +142.0% |
| 2006 | -1.16x | $-5.00 Million | $4.30 Million | ▲ +61.4% |
| 2005 | -3.01x | $-8.30 Million | $2.76 Million | ▲ +45.0% |
| 2004 | -5.48x | $-10.44 Million | $1.91 Million | ▲ +12.6% |
| 2003 | -6.27x | $-5.52 Million | $881.21K | ▼ -98.7% |
| 2002 | -3.15x | $-3.96 Million | $1.26 Million | ▼ -60.5% |
| 2001 | -1.97x | $-1.82 Million | $927.76K | ▲ +42.3% |
| 2000 | -3.41x | $-3.21 Million | $941.26K | ▲ +37.3% |
| 1999 | -5.43x | $-1.79 Million | $329.12K | ▼ -46.1% |
| 1998 | -3.72x | $-3.04 Million | $817.91K | — |